Schedule 13G ownership disclosure
PLX PHARMA INC. XXXBANKRUPTCY EFF: 10/02/23
Security class unavailable · CUSIP: 72942A107
Event date: 2023-04-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,437,249
- Percent of class
- 4.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-23-011138
- Form type
- SC 13G
- Filer
- PLx Pharma Inc.
- CIK
- CIK 1497504
- Filed
- Apr 06, 2023
- Reporting period
- Apr 04, 2023
- Description
- Schedule 13G beneficial ownership